Morgan Stanley’s Incannex Healthcare IXHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.2K Buy
2,065
+665
+48% +$4.84K ﹤0.01% 7088
2025
Q4
$15K Sell
1,400
-1,333
-49% -$15.4K ﹤0.01% 6789
2025
Q3
$38.1K Buy
2,733
+1,738
+175% +$28.2K ﹤0.01% 6493
2025
Q2
$6.44K Sell
995
-670
-40% -$6.62K ﹤0.01% 6965
2025
Q1
$33.8K Sell
1,665
-217
-12% -$9.42K ﹤0.01% 6403
2024
Q4
$120K Buy
1,882
+587
+45% +$35.3K ﹤0.01% 5986
2024
Q3
$77.3K Buy
1,295
+300
+30% +$18.5K ﹤0.01% 6091
2024
Q2
$87.8K Hold
995
﹤0.01% 6003
2024
Q1
$107K Buy
+995
New +$120K ﹤0.01% 5966
2023
Q2
Sell
-23
Closed -$6.04K 7684
2023
Q1
$6.04K Buy
23
+19
+475% +$6.42K ﹤0.01% 7013
2022
Q4
$1.4K Hold
4
﹤0.01% 7421
2022
Q3
$2K Sell
4
-5
-56% -$2.62K ﹤0.01% 7472
2022
Q2
$4K Sell
9
-158
-95% -$128K ﹤0.01% 7452
2022
Q1
$183K Buy
+167
New +$276K ﹤0.01% 5975

Other funds holding IXHL

Morgan Stanley's IXHL Position: Q1 2026 in Review

Morgan Stanley increased its Incannex Healthcare (IXHL) stake by 48% in Q1 2026, buying an estimated $4.84K and bringing the position to 2,065 shares worth $6.2K. The position accounts for ﹤0.01% of the portfolio, ranked #7088.

Morgan Stanley first reported a position in IXHL in Q1 2022 and has held it in 14 quarters since. The position peaked at $183K in Q1 2022. 21 funds tracked by Wall St. Rank hold IXHL as of Q1 2026.

  • Morgan Stanley held 2,065 shares of Incannex Healthcare worth $6.2K as of Q1 2026.
  • Morgan Stanley bought 665 Incannex Healthcare shares in Q1 2026, an estimated $4.84K.
  • Incannex Healthcare made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7088 holding.
  • Morgan Stanley first reported a position in Incannex Healthcare in Q1 2022 and has held it in 14 quarters since.
  • Morgan Stanley's Incannex Healthcare position peaked at $183K in Q1 2022.
  • 21 funds tracked by Wall St. Rank held Incannex Healthcare as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.